p,p'-DDE and Breast Cancer Cell Growth
Author Information
Author(s): Aubé Michel, Larochelle Christian, Ayotte Pierre
Primary Institution: Unité de Recherche en Santé Publique, Centre de Recherche du Centre Hospitalier Universitaire de Québec-CHUL
Hypothesis
Does p,p'-DDE disrupt the estrogen-androgen balance and promote the growth of hormone-dependent breast cancer cells?
Conclusion
p,p'-DDE may increase breast cancer progression by disrupting the androgen signaling pathway that normally inhibits growth in hormone-responsive breast cancer cells.
Supporting Evidence
- p,p'-DDE increased the proliferation of CAMA-1 cells in the presence of estrogens and androgens.
- DHT reduced the proliferative response of CAMA-1 cells, which was blocked by p,p'-DDE.
- p,p'-DDE induced a dose-response increase in cell proliferation.
- p,p'-DDE also increased the expression of cyclin D1, a key regulator of cell cycle progression.
Takeaway
p,p'-DDE, a chemical from DDT, can make breast cancer cells grow faster by messing with the hormones that usually keep them in check.
Methodology
The study tested the effect of p,p'-DDE on the proliferation of CAMA-1 breast cancer cells in the presence of estrogens and androgens over a 9-day period.
Limitations
The study is limited to in vitro findings and may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website